Literature DB >> 17348295

Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza.

Matthew W Smith1, Jeffrey E Schmidt, Jerold E Rehg, Carlos J Orihuela, Jonathan A McCullers.   

Abstract

Mortality after influenza is often due to secondary bacterial pneumonia with Streptococcus pneumoniae, particularly in the elderly. The reasons for the high fatality rate seen with this disease are unclear. To further characterize the pathogenesis of pneumonia after influenza in a mouse model, we examined the pathology and immunology that leads to fatal infection. Influenza-infected mice were either euthanized 24 h after secondary infection with S. pneumoniae for determination of pathology, bacterial cultures, and levels of immune effectors or were followed by use of a live imaging system for development of pneumonia. Influenza-infected mice challenged with each of 3 serotypes of pneumococcus developed a severe, necrotic pneumonia and met endpoints for euthanasia in 24 to 60 h. Strikingly elevated levels of both pro- and anti-inflammatory molecules including interleukins 6 and 10, macrophage inflammatory protein 1alpha, and chemokine KC were present in the blood. High levels of these cytokines and chemokines as well as tumor necrosis factor alpha, interleukin 1beta, and heme oxygenase 1 were present in the lungs, accompanied by a massive influx of neutrophils. Mortality correlated with the development of pneumonia and lung inflammation but not with bacteremia. This model has the potential to help us understand the pathogenesis of severe lung infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17348295      PMCID: PMC2736785     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  37 in total

Review 1.  Molecular machinations: chemokine signals in host-pathogen interactions.

Authors:  S W Chensue
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Invasive pneumococcal infections. A comparison between adults and children.

Authors:  G Rahav; Y Toledano; D Engelhard; A Simhon; A E Moses; T Sacks; M Shapiro
Journal:  Medicine (Baltimore)       Date:  1997-07       Impact factor: 1.889

3.  The effect of antibiotics (penicillin, aureomycin, and terramycin) on the fatality rate and incidence of complications in pneumococcic pneumonia; a comparison with other methods of therapy.

Authors:  H F DOWLING; M H LEPPER
Journal:  Am J Med Sci       Date:  1951-10       Impact factor: 2.378

4.  Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron.

Authors:  D M Suttner; P A Dennery
Journal:  FASEB J       Date:  1999-10       Impact factor: 5.191

5.  Interleukin-10 impairs host defense in murine pneumococcal pneumonia.

Authors:  T van der Poll; A Marchant; C V Keogh; M Goldman; S F Lowry
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

Review 6.  Molecular pathogenesis of pneumococcal pneumonia.

Authors:  J A McCullers; E I Tuomanen
Journal:  Front Biosci       Date:  2001-08-01

7.  Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae.

Authors:  Jonathan A McCullers; Kimberly C Bartmess
Journal:  J Infect Dis       Date:  2003-03-06       Impact factor: 5.226

8.  Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza.

Authors:  Jonathan A McCullers
Journal:  J Infect Dis       Date:  2004-06-30       Impact factor: 5.226

9.  Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor.

Authors:  Jonathan A McCullers; Jerold E Rehg
Journal:  J Infect Dis       Date:  2002-07-10       Impact factor: 5.226

Review 10.  Chemokines in acute respiratory distress syndrome.

Authors:  Padmam Puneet; Shabbir Moochhala; Madhav Bhatia
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-01       Impact factor: 5.464

View more
  74 in total

1.  Immunopathogenic and antibacterial effects of H3N2 influenza A virus PB1-F2 map to amino acid residues 62, 75, 79, and 82.

Authors:  Irina V Alymova; Amanda M Green; Nicholas van de Velde; Julie L McAuley; Kelli L Boyd; Hazem E Ghoneim; Jonathan A McCullers
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

Review 2.  A shift from cell cultures to creatures: in vivo imaging of small animals in experimental regenerative medicine.

Authors:  Anna J Studwell; Darrell N Kotton
Journal:  Mol Ther       Date:  2011-09-27       Impact factor: 11.454

Review 3.  Postinfluenza bacterial pneumonia: host defenses gone awry.

Authors:  Megan N Ballinger; Theodore J Standiford
Journal:  J Interferon Cytokine Res       Date:  2010-09       Impact factor: 2.607

4.  Clinical and demographic characteristics of seasonal influenza in pediatric patients with cancer.

Authors:  Silvana B Carr; Elisabeth E Adderson; Hana Hakim; Xiaoping Xiong; Xiaowei Yan; Miguela Caniza
Journal:  Pediatr Infect Dis J       Date:  2012-11       Impact factor: 2.129

5.  Deletions in the neuraminidase stalk region of H2N2 and H9N2 avian influenza virus subtypes do not affect postinfluenza secondary bacterial pneumonia.

Authors:  Ashok K Chockalingam; Danielle Hickman; Lindomar Pena; Jianqiang Ye; Andrea Ferrero; Jose R Echenique; Hongjun Chen; Troy Sutton; Daniel R Perez
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

6.  Immunomodulators targeting MARCO expression improve resistance to postinfluenza bacterial pneumonia.

Authors:  Muzo Wu; John G Gibbons; Glen M DeLoid; Alice S Bedugnis; Rajesh K Thimmulappa; Shyam Biswal; Lester Kobzik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-04-13       Impact factor: 5.464

7.  Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia.

Authors:  Julie L McAuley; Felicita Hornung; Kelli L Boyd; Amber M Smith; Raelene McKeon; Jack Bennink; Jonathan W Yewdell; Jonathan A McCullers
Journal:  Cell Host Microbe       Date:  2007-10-11       Impact factor: 21.023

Review 8.  Streptococcus adherence and colonization.

Authors:  Angela H Nobbs; Richard J Lamont; Howard F Jenkinson
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

9.  Helminth infections predispose mice to pneumococcal pneumonia but not to other pneumonic pathogens.

Authors:  Nopporn Apiwattanakul; Paul G Thomas; Raymond E Kuhn; De'Broski R Herbert; Jonathan A McCullers
Journal:  Med Microbiol Immunol       Date:  2014-06-21       Impact factor: 3.402

Review 10.  Animal models for the study of influenza pathogenesis and therapy.

Authors:  Dale L Barnard
Journal:  Antiviral Res       Date:  2009-01-25       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.